Is this Alzheimer's drug a breakthrough for millions? Company unveils mixed results

Biogen will seek FDA approval for an Alzheimer's drug with mixed results. Can this experimental medication slow the memory-robbing disease?

      

from USATODAY - News Top Stories https://ift.tt/33WxtAi
Ken Alltucker, USA TODAY

Biogen will seek FDA approval for an Alzheimer's drug with mixed results. Can this experimental medication slow the memory-robbing disease?

      

https://ift.tt/1roPe8M December 06, 2019 at 12:09AM